0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Why Are Clinical Biomarker Testing Services a Top Priority in Precision Medicine?According to the latest report published by Data Bridge Market Research, the Clinical Biomarker Testing Services Market CAGR Value As per Data Bridge Market Research analysis, the clinical biomarker testing services market was valued at USD 9.68 billion in 2025 and is projected to reach USD 18.45 billion by 2033, growing at a CAGR of 8.40% from 2026 to 2033. The Clinical Biomarker...0 Комментарии 0 Поделились 764 Просмотры 0 предпросмотр
-
Clonality-Based Testing Using ABI Fluorescence Detection: Advancing Precision in Hematologic DiagnosticsIn modern oncology and molecular diagnostics, the ability to accurately identify and characterize clonal cell populations has become essential. Clonality-based testing, particularly using ABI fluorescence detection, plays a critical role in diagnosing and monitoring hematological malignancies such as leukemia and lymphoma. With advancements in PCR-based technologies and capillary...0 Комментарии 0 Поделились 15Кб Просмотры 0 предпросмотр
-
How Automation Is Reshaping In Vitro Diagnostics Quality Control Market GrowthThe In Vitro Diagnostics Quality Control Market is gaining importance as clinical laboratories and healthcare providers place greater emphasis on accurate, reliable, and consistent diagnostic testing. The market was valued at USD 1.3 billion in 2023 and is projected to grow from USD 1.4 billion in 2026 to USD 1.6 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030. The increasing...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Immunoassay Market: ELISA, CLIA Tech & Kits/Reagents Diagnostic Analysis" Exactitude Consultancy That Adds Flavour To Your Success" Immunoassay Market size and trends. ELISA and CLIA diagnostics for infectious diseases, oncology, and endocrinology in hospital labs. The global Immunoassay Market is projected to reach USD 34.50 Billion in 2026 and USD 52.40 Billion by 2033, growing at a 6.1% CAGR. If you're looking for insights into the Immunoassay Market,...0 Комментарии 0 Поделились 6Кб Просмотры 0 предпросмотр